Clinical trials: Severe ARDS

ARDS

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS

• Completed
• Age: 18 years and older
• Phase 2

This phase IIb, randomized, placebo-controlled, double-blind, dose escalation study will assess the local and systemic safety of 7 days orally inhaled sequential multiple ascending doses of solnatide in patients with pulmonary…

Trial name

NCT03567577

Testing

Solnatide 25 mg powder for reconstitution for solution for inhalation, 0.9% Saline Solution

Where

15 sites in Austria, Germany

Volunteers

92 people

Sponsor

Apeptico Forschung und Entwicklung GmbH